Anonymised HIV-1 sequence data has been submitted to Genbank with accession numbers MT748056-MT748757. Sufficient data to reproduce Tables [2](#pone.0237469.t002){ref-type="table"} & [3](#pone.0237469.t003){ref-type="table"} and [Fig 3](#pone.0237469.g003){ref-type="fig"} have been included as a Supplementary file ([S1 Dataset](#pone.0237469.s002){ref-type="supplementary-material"}). Additional data can be requested from the Victorian Department of Health and Human Services.

Introduction {#sec005}
============

Heterosexual sexual transmission of HIV accounts for approximately 20% of new HIV notifications in Australia annually and has remained stable from 2008--2017, with migrants making up approximately 40% of these notifications \[[@pone.0237469.ref001]--[@pone.0237469.ref006]\]. Although many HIV infections among those migrating from high prevalence countries to low prevalence countries are likely to be acquired before migration, migrants may also be vulnerable to acquiring HIV in the destination country \[[@pone.0237469.ref007], [@pone.0237469.ref008]\]. Results from a study of HIV in heterosexual migrants in the United Kingdom (UK) from 2004--2010 using CD4 cell counts at diagnosis and a subsequent study migrants diagnosed at 57 clinics across Europe between 2013--2015 using a combination of clinical and self-report data, indicated that 33% and 63% of diagnosed HIV cases, respectively, were likely to have been acquired post-migration \[[@pone.0237469.ref009], [@pone.0237469.ref010]\]. We previously applied a CD4 count model to data from HIV notifications with heterosexual exposure to HIV in the Australian state of Victoria, with the results suggesting that approximately 50% of migrants were likely to have acquired their HIV post-migration to Australia \[[@pone.0237469.ref003]\].

Molecular epidemiology, including phylogenetic analysis, is increasingly being used as to monitor and characterise HIV transmission and inform public health and prevention responses \[[@pone.0237469.ref011]--[@pone.0237469.ref014]\]. Molecular epidemiology has also been used to demonstrate increases in non-B subtypes in Australia and several European countries \[[@pone.0237469.ref015]--[@pone.0237469.ref023]\], and to estimate the number of infections likely to have been acquired post-migration in some cases \[[@pone.0237469.ref022]\]. However, these studies have not examined the characteristics of phylogenetic clusters, beyond using them to determine acquisition post-migration. A mathematical model of HIV infection in the Netherlands found that highly assortative sexual mixing between migrants who came from the same region of origin resulted in higher HIV prevalence among migrants \[[@pone.0237469.ref024]\]. We used phylogenetic analysis and subtyping of routine HIV *pol* sequencing (undertaken as part of clinical care) to better understand heterosexual HIV risk and transmission among migrants and explore the role of networks in transmission.

Methods {#sec006}
=======

Study population {#sec007}
----------------

The key population of interest was migrants in the Australian state of Victoria who were newly diagnosed with HIV and reported heterosexual sexual contact as the route of transmission. Victoria is Australia's second most populous state and has the second highest number of people diagnosed with HIV and new HIV diagnoses \[[@pone.0237469.ref025], [@pone.0237469.ref026]\].

We included all migrants with new HIV diagnoses aged ≥18 years notified to the Victorian Department of Health and Human Services, where the likely exposure to HIV was recorded as heterosexual sexual contact. People born in any country other than Australia or New Zealand, were classified as migrants, irrespective of citizenship status, and Australian and New Zealand-born individuals were classified as non-migrants. Consistent with previous analyses, New Zealanders were grouped with Australian-born people \[[@pone.0237469.ref003]\]. In addition, the following notifications were used to facilitate characterisation of phylogenetic clusters among cases classified as heterosexually acquired: all notifications in non-migrants aged≥18 years attributed to heterosexual sexual contact and all notifications attributed to bisexual sexual contact or injecting drug use (including those attributed to injecting drug use and male-to-male sex \[MSM\]) in those ≥18 years irrespective of migrant status.

Data sources {#sec008}
------------

The Victorian Department of Health and Human Services receives notifications of HIV from both the laboratories performing the test and the diagnosing doctors, as mandated by the Public Health and Wellbeing Act 2008 and its associated regulations. Notification data were obtained from 1^st^ January 2000 (as very little sequencing was done prior to 2000) to 30^th^ of June 2014. From 2000--2004 relatively few HIV notifications were sequenced. Therefore, although these sequences were included in the phylogenetic analysis to allow for possible clustering with later notifications, notifications from 2005 onward were the focus of the analysis.

Patient characteristics {#sec009}
-----------------------

Patient and associated diagnosis characteristics including date of diagnosis, patient demographics (sex and date and country of birth), clinical characteristics at the time of diagnosis (CD4 count, any reported symptomatology), HIV testing history (date and result of the previous HIV test), possible route/s of exposure, likely country of exposure and year of arrival to Australia (for people born outside of Australia or New Zealand) were extracted from notifications data. Multiple HIV exposures can be selected on the notification form: for the purpose of these analyses, exposures were categorised as heterosexual sex (where heterosexual sexual contact was the only reported exposure), bisexual (where MSM and heterosexual sexual contact were both listed on the form), heterosexual sex with injecting drug use, MSM with injecting drug use and other/unknown.

HIV sequence data {#sec010}
-----------------

Sanger sequencing of the HIV *pol* gene is used in routine clinical practice to determine antiretroviral drug susceptibility and HIV subtype. Pre-treatment HIV *pol* sequences were identified for the period 2000--2014 in the Victorian Infectious Diseases Reference Laboratory (VIDRL) database and the Burnet Institute Clinical Research Laboratory HIV database, where clinical samples from patients with HIV infection receiving their clinical care at The Alfred hospital (a Victorian HIV care service), were routinely sequenced as part of HIV genotype testing during this period. Both laboratories participated in quality assurance programs. Data were linked with HIV notifications by matching name codes (the first two letters of cases' first name and surname) and date of birth, recorded in all three datasets.

Reference sequences were selected from the Los Alamos database using a stratified random sample, with strata defined by country of birth and viral subtype. Where available, three sequences were selected from each country of birth and viral subtype combination represented in the study sample. The final sample included 177 reference sequences.

Classifying notifications on the basis of the probable timing of HIV acquisition relative to migration {#sec011}
------------------------------------------------------------------------------------------------------

For our analyses, evidence of probable place of HIV acquisition was classified as "strong", "medium" or "weak" on the basis of testing history, laboratory evidence of recent infection and CD4 count at diagnosis. Those individuals with a clinic and/or laboratory-confirmed previous negative HIV test post-migration to Australia and those with laboratory evidence of recent infection (group IV indeterminate Western blot and HIV detected by virological assay) post-migration to Australia were classified as having strong evidence of HIV acquisition post-migration. Those with a self-reported previous negative HIV test post-migration to Australia were classified as having medium evidence of HIV acquisition post-migration.

Weak evidence of place of acquisition was classified on the basis of their CD4 count at diagnosis. We adopted the formulae used in the UK's HIV & AIDS New Diagnoses & Deaths Database \[[@pone.0237469.ref003], [@pone.0237469.ref009]\] which estimates time since HIV acquisition based on modelled estimates of the median estimated CD4 counts at HIV acquisition and the median rate of CD4 decline after diagnosis. We used known CD4 count at diagnosis from our dataset to estimate time between HIV exposure and diagnosis which we subtracted from date of diagnosis to estimate date of acquisition and upper and lower confidence intervals for this estimate \[[@pone.0237469.ref003], [@pone.0237469.ref009]\]. If the year of arrival to Australia was before the lower bound confidence interval of the estimated year of acquisition, a HIV case was classified as weak evidence of acquisition post-migration. All other cases including those where the bounds of the confidence interval around estimated year of acquisition included year of arrival were classified as weak evidence of having acquired their infection before migration \[[@pone.0237469.ref003]\].

Those notifications in migrants that could not be classified using any of the methods above (no evidence of recent infection, no negative test in Australia and either CD4 count or year of migration not available), location of HIV acquisition were classified as unknown.

Sequencing methods {#sec012}
------------------

A 1035 base-pair product spanning the entire coding region for protease (PR) and the first 246 codons of reverse transcriptase (RT) was amplified from HIV-1-specific RNA derived from 500 μL of plasma and sequenced using the ABI Prism reagents, hardware and software (Applied Biosystems, Foster, CA; HXB2 co-ordinates of the sequence dataset set are 2253--3287). The methods have been described in detail previously \[[@pone.0237469.ref015]\]. HIV strains were initially subtyped based on their *pol* sequences using the Stanford HIV database (<http://hivdb.stanford.edu/>). Subtype assignment was confirmed by submitting sequences to the Los Alamos database ([http://www.hiv.lanl.gov](http://www.hiv.lanl.gov/)) and the NCBI HIV genotyping tool (<http://www.ncbi.nlm.nih.gov/projects/genotyping/>). If subtype assignment was unclear due to potential recombination, Recombinant Identification Program (<https://www.hiv.lanl.gov/content/sequence/RIP/RIP.html>) and Jumping Profile Hidden Markov Model (<http://jphmm.gobics.de/>) were used to assign the subtype.

Phylogenetic analysis {#sec013}
---------------------

Sequences were aligned using the Bio Edit tool ([mbio.ncsu.edu/BioEdit](http://www.mbio.ncsu.edu/BioEdit/bioedit.html)). Codons associated with drug resistance were removed to avoid clustering due to convergent evolution (hivdb.stanford.edu/s/who). The nucleotide substitution model was selected based on the Akaike Information Criteria. Maximum likelihood methods used to construct a phylogenetic tree using Mega 6.0 \[[@pone.0237469.ref027]\] based on the general time reversible nucleotide substitution model with gamma distribution and a proportion of invariable sites. The robustness of the resulting tree was assessed using bootstrap with 1000 replicates.

Phylogenetic clusters were defined on the basis of genetic distance (\<0.045) and bootstrap support (\>0.95) using the command line version of ClusterPicker version 1.2. Genetic distance was defined using ClusterPicker's "ambiguity" method which is the p-distance for A, C, T, G sites and sites with IUPAC ambiguity codes. The characteristics of phylogenetic clusters were visualised using Pajek 5.07.

Statistical analysis {#sec014}
--------------------

Chi-squared (categorical variables) and Kruskal-Wallis tests (numeric variables) were used to assess differences in notification characteristics between migrants and non-migrants. Potential associations between phylogenetic cluster size and the composition of the clusters were assessed using Fisher's exact (categorical variables) and Kruskal-Wallis tests (numeric variables). The probability that phylogenetic clusters containing migrants from the same country of origin would be observed by chance was assessed by calculating the binomial probability of same country clusters being observed given that the largest group of migrants migrating from the same country was 45 and 876 sequences were included in the phylogenetic analysis.

We assessed factors associated with phylogenetic clustering using univariable and multivariable logistic regression associated with phylogenetic clustering, with a backward selection approach used to build the multivariable model which initially included variables whose p-value was \<0.25 in univariable regression. The cut-off for statistical significance for all analyses was p\<0.05.

Ethics {#sec015}
------

Approval for the study including a waiver of informed consent for use of retrospective data was granted by The Alfred Office of Ethics and Research Governance (project 218/14).

Results {#sec016}
=======

There were 445 new HIV diagnoses in Victoria between 2005--2014 in people reporting heterosexual sex as the only exposure ([Fig 1](#pone.0237469.g001){ref-type="fig"}). Of these, 332 (75%) had *pol* sequence data available. The characteristics of new HIV diagnoses with sequence data available are described in [Table 1](#pone.0237469.t001){ref-type="table"}. Compared to individuals born in Australia/New Zealand, migrants were on average younger at notification (median 36 years vs 42 years, p = 0.013) and less likely to have evidence of newly acquired infection (9% vs 21%, p = 0.003). Among migrants, the most common region of birth was sub-Saharan Africa (35%) followed by South-East Asia (22%). The HIV-1 subtype distribution was substantially different among migrants (22% B, 41% C, 24% CRF01_AE, 13% other) compared to Australian/New Zealand-born individuals (63% B, 12% C, 21% CRF01_AE, 4% other; p\<0.001, [Table 1](#pone.0237469.t001){ref-type="table"}). Availability of HIV partial *pol* sequence did not differ by age, sex, country of birth (Australian/New Zealand born vs migrant), or CD4 count.

![Flow chart of study inclusion.](pone.0237469.g001){#pone.0237469.g001}

10.1371/journal.pone.0237469.t001

###### Characteristics of 332 HIV notifications with heterosexual exposure category and *pol* sequences available, 2005--2014.

![](pone.0237469.t001){#pone.0237469.t001g}

                                                                                      Migrants            Australian/NZ-born   p-value[^a^](#t001fn001){ref-type="table-fn"}
  ----------------------------------------------------------------------------------- ------------------- -------------------- -----------------------------------------------
  **N**                                                                               206                 126                  
  **Sex at birth**                                                                                                             
      Male                                                                            109 (53)            79 (63)              0.081
      Female                                                                          97 (47)             47 (37)              
  **Median age at HIV diagnosis (IQR)**                                               36.1 (30.1--46.8)   42.3 (31.5--50.6)    0.013
  **Year of HIV diagnosis**                                                                                                    
      2005--2009                                                                      108 (52)            61 (48)              0.478
      2010--2014                                                                      98 (48)             65 (52)              
  **Median CD4 count at HIV diagnosis (IQR)[^b^](#t001fn002){ref-type="table-fn"}**   243 (70--430)       304 (102--538)       0.068
  **Evidence of newly acquired infection**                                                                                     
      Yes                                                                             19 (9)              26 (21)              0.003
      No                                                                              187 (91)            100 (79)             
  **Region of birth**                                                                                                          N/A
      North Africa and Middle East                                                    13 (6)              \-                   
      Americas                                                                        5 (2)               \-                   
      North East Asia                                                                 7 (3)               \-                   
      South East Asia                                                                 46 (22)             \-                   
      Southern and Central Asia                                                       17 (8)              \-                   
      North and West Europe                                                           20 (10)             \-                   
      South and East Europe                                                           11 (5)              \-                   
      Oceania                                                                         7 (3)               126 (100)            
      Sub-Saharan Africa                                                              71 (35)             \-                   
      Unknown                                                                         9 (4)               \-                   
  **HIV-1 subtype**                                                                                                            
      B                                                                               45 (22)             80 (63)              \<0.001
      C                                                                               85 (41)             15 (12)              
      CRF01_AE                                                                        49 (24)             26 (21)              
      Other                                                                           27 (13)             5 (4)                

^a^*p-value* for difference between migrants and Australian born cases.

^b^35 migrants and 32 Australian-born cases missing CD4 count data.

Phylogenetic clustering {#sec017}
-----------------------

Overall, 876 sequences were included in the phylogenetic analysis, including reference sequences (Figs [1](#pone.0237469.g001){ref-type="fig"} and [2](#pone.0237469.g002){ref-type="fig"}). Of these, 258 (29%) were in 92 phylogenetic clusters. Of the 332 notifications from 2005 onward where heterosexual sex was listed as the only exposure and *pol* sequences were available, 206 (62%) were from migrants and 126 (38%) were Australian/NZ born, with 118 (36%) samples in 65 phylogenetic clusters. Of these 118 samples identified in a cluster, 66 (56%) were migrants and 52 (44%) were Australian/NZ-born notifications. Based on multivariable analysis, newly acquired infection, region of birth ("Other" compared to sub-Saharan Africa) and B- subtype were independent predictors of phylogenetic clustering ([S1 Table](#pone.0237469.s001){ref-type="supplementary-material"}).

![Maximum likelihood phylogeny of HIV *pol* sequences from Australian HIV notifications and international reference sequences.](pone.0237469.g002){#pone.0237469.g002}

Australian HIV notifications include 206 in migrants to Australia with heterosexual exposure from 2005--2014 and 493 other Australian HIV notifications from 2000--1014. International reference sequences (n = 177) were sampled from the Los Alamos database. Phylogenetic clusters, identified on the basis of bootstrap value and genetic distance, are coloured red.

Of the 65 phylogenetic clusters identified, 43 contained at least one migrant who reported heterosexual sex as the only mode of transmission ([Fig 3](#pone.0237469.g003){ref-type="fig"}). The size of the clusters ranged from 2--10 with 30 clusters (70%) consisting of pairs (cluster size = 2) ([Fig 3](#pone.0237469.g003){ref-type="fig"}). The characteristics of the pairs were considerably different to those of the larger clusters ([Table 2](#pone.0237469.t002){ref-type="table"}, [Fig 3](#pone.0237469.g003){ref-type="fig"}). Compared to clusters larger than two, pairs were more likely to include at least one female (87% vs. 54% of clusters larger than 2, p = 0.037) and more likely to be composed of migrants from the same country of origin (40% vs 0% of clusters larger than 2; p = 0.032). Larger clusters were more likely to include bisexual/MSM-IDU (70% vs. 17% of pairs; p\<0.001), people born in Australia/New Zealand (including people from multiple countries of origin) (92% vs 40% of pairs; p = 0.002) and people from multiple countries of origin that do not include Australia (62% vs. 21% of pairs, p = 0.013) The proportion of clusters that included heterosexual migrants with any (p = 0.890) or strong (p = 1.000) evidence of HIV acquisition after migration did not differ by cluster size ([Table 2](#pone.0237469.t002){ref-type="table"}).

![The characteristics of 43 phylogenetic clusters containing at least one migrant with heterosexual exposure to HIV.\
Each circle represents an HIV notification. Lines connect notifications within the same cluster. The symbols in the centre of each circle represent the exposure to HIV listed on the notification form. The colour of the symbol in the centre of each circle represents sex. The fill colour of the circle represents migrant status, estimate and level of evidence for timing of HIV acquisition relative to migration.](pone.0237469.g003){#pone.0237469.g003}

10.1371/journal.pone.0237469.t002

###### Characteristics of 43 phylogenetic clusters containing at least one heterosexual migrant with new HIV diagnosis, 2005--2014.

![](pone.0237469.t002){#pone.0237469.t002g}

                                                                                                            Size of cluster   p-value                           
  --------------------------------------------------------------------------------------------------------- ----------------- ---------------- ---------------- ---------
  **Total number of clusters**                                                                              30                5                8                
  ***Sex of cluster members***                                                                                                                                  
      Cluster includes females: n (%)                                                                       26 (87)           3 (60)           4 (50)           0.037
      Proportion of cluster female: median (IQR)                                                            0.5 (0.5--0.5)    0.3 (0.0--0.7)   0.1 (0.0--0.3)   0.001
  ***Sexual orientation and sexual behaviour of cluster members***                                                                                              
      Cluster includes MSM: n (%)                                                                           5 (17)            2 (40)           7 (88)           \<0.001
      Cluster includes bisexuals: n (%)                                                                     4 (13)            1 (20)           7 (88)           \<0.001
      Proportion of cluster MSM: median (IQR)                                                               0.0 (0.0--0.0)    0.0 (0.0--0.3)   0.5 (0.4--0.6)   \<0.001
  ***Injecting drug use in the cluster***                                                                                                                       
      Cluster includes PWID (including MSM who inject drugs): n (%)                                         2 (7)             1 (20)           7 (88)           \<0.001
      Cluster includes PWID (excluding MSM): n (%)                                                          1 (3)             0 (0)            1 (13)           0.518
      Proportion of cluster reporting injecting drug use (includes MSM): median (IQR)                       0.0 (0.0--0.0)    0.0 (0.0--0.0)   0.2 (0.1--0.3)   \<0.001
  ***Country of origin in the cluster***                                                                                                                        
      Cluster composed only of migrants from one country of origin: n (%)                                   12 (40)           0 (0)            0 (0)            0.032
      Cluster includes Australian/NZ born: n (%)                                                            12 (40)           4 (80)           8 (100)          0.002
      Cluster includes migrants from two or more countries of origin: n (%)                                 6 (21)            2 (40)           6 (75)           0.013
      Number of different countries of origin per cluster (includes Aust/NZ): median (IQR)                  2 (1--2)          2 (2--2)         3 (3--4)         \<0.001
      Proportion of cluster Australian/NZ born: median (IQR)                                                0.0 (0.0--0.5)    0.3 (0.3--0.3)   0.6 (0.5--0.6)   0.002
  ***Viral subtype of cluster***                                                                                                                                
      B: n (%)                                                                                              8 (27)            2 (40)           7 (88)           0.006
  ***Timing of HIV infection among heterosexual migrants in the cluster***                                                                                      
      Cluster includes heterosexual migrants with any evidence of HIV infection after migration: n (%)      18 (60)           3 (60)           4 (50)           0.890
      Cluster includes heterosexual migrants with strong evidence of HIV infection after migration: n (%)   10 (33)           1 (20)           3 (38)           1.000

The denominators for all percentages are the total number of clusters in the column. p-values for differences between clusters of different sizes (n = 2, n = 3, n≥4) based on Fisher's exact test for categorical variables and Kruskal Wallis test for continuous variables.

Of the 43 phylogenetic clusters including 67 migrants who reported heterosexual sex as their only mode of transmission, 22 individuals (33%) were in 12 clusters with only migrants from the same country (Tables [2](#pone.0237469.t002){ref-type="table"} & [3](#pone.0237469.t003){ref-type="table"}). Of the 22, HIV acquisition was estimated to have occurred before migration for nine, seven after migration and six were unknown ([Table 3](#pone.0237469.t003){ref-type="table"}). Given that there were 876 sequences in the analysis and the largest group migrating from the same country was 45, the probability of observing a same-country pair by chance was p = 0.003. Therefore, the observation of 12 same country pairs overall and seven same country pairs with evidence of infection acquired after migration, were statistically significant (both p\<0.001). Nonetheless, these observed infections in single-country clusters accounted for a minority (7/29; 24%) of all Australian acquired infections among migrants.

10.1371/journal.pone.0237469.t003

###### Single country of origin clustering among 67 heterosexual migrants with new HIV notification 2005--2014 who are members of phylogenetic clusters, by timing of HIV acquisition relative to migration.

![](pone.0237469.t003){#pone.0237469.t003g}

                                                 Number of notifications   Cluster with only same country migrants
  ---------------------------------------------- ------------------------- -----------------------------------------
  **Total**                                      67                        22 (33)
  *Strong evidence acquired after migration*     12                        3 (25)
  *Moderate evidence acquired after migration*   4                         0 (0)
  *Weak evidence acquired after migration*       13                        4 (31)
  *Weak evidence acquired before migration*      16                        9 (56)
  *Unknown*                                      22                        6 (27)

Discussion {#sec018}
==========

This study examined the characteristics of phylogenetic clusters involving heterosexual migrants living in Victoria, Australia from 2005--2014. The majority (70%) of 43 clusters that included at least one migrant with heterosexual risk were pairs and all clusters with more than one migrant from a single country of origin were pairs. The number of same country migrant pairs that we observed was significantly greater than expected by chance, including among pairs with evidence of post-migration acquisition of HIV. Whilst this suggests that the sexual networks among migrants from the same country of origin does contribute to the risk of HIV infection after migration, the overall number of same country-of-origin clusters was small and confined to pairs rather than larger clusters. In addition, the risk of heterosexually acquired infection among migrants appears to be partially attributable to sex between migrants from the same country (within couples) and partially attributable to risk from sex with those born in Australian/New Zealand, including those reporting male-to-male sex.

The eight clusters consisting of four or more notifications included mainly men, people born in Australian/NZ and migrants from multiple countries of origin, and those reporting male-to-male sex as a possible route of HIV acquisition. These clusters were also mainly viral subtype B, the predominant HIV subtype transmitted through male-to-male sex in Australia \[[@pone.0237469.ref005]\]. These findings suggest that migrants in larger clusters are predominantly acquiring their HIV after migration and HIV risk is occurring through sexual contact with people born in Australia/New Zealand and may include male-to-male sex. Further work is required to see how well-connected sequences from migrants are with those from the Australian gay community. It is possible that some of the reported heterosexual exposures in these clusters were due to male-to-male sexual exposure that was not reported due to social desirability bias, which may be higher among migrants from countries or cultures where male-to-male sex is stigmatised. A recent study of Australian HIV diagnoses in migrants found that diagnoses attributable to male-to-male sex appeared to be increasing in migrants from several regions of origin, although this was based only on a comparison between two periods rather than an analysis of trends \[[@pone.0237469.ref006]\].

To the best of our knowledge, the only published study of HIV transmission networks in migrants is a mathematical modelling study of the heterosexual HIV epidemic in the Netherlands, which investigated the effects of sexual mixing patterns on the epidemic \[[@pone.0237469.ref024]\]. Modelled estimates based on empirical data on sexual mixing and sexual behaviour from cross-sectional surveys suggested that the majority of HIV infections in migrants from high prevalence countries were acquired in the Netherlands, but the epidemic was very stable due to low levels of risk behaviour among migrants and highly assortative mixing within migrants from the same region. That study focussed on only migrants from high and medium HIV prevalence regions whereas our study was on all heterosexual migrant notifications. Sexual mixing and sexual behaviour among migrants to Australia may differ from migrants to the Netherlands. Nonetheless, a key finding of the modelling study was that the heterosexual epidemic in the Netherlands was stable due to low levels of risk behaviour among migrants from high prevalence countries. This finding is consistent with the findings of our study in that phylogenetic clusters consistent with heterosexual transmission alone were small (all n≤3 and most n = 2).

The results of our study suggest the risk of HIV acquisition among heterosexual migrants to Australia post-migration is from a variety of sources; for some this is within country of origin networks including transmission before or after migration and for others it is following migration and is related to the Australian predominantly MSM HIV epidemic. The proportion with evidence of acquisition after migration did not vary with cluster size, highlighting that HIV risk for migrants after migration is hybrid, both from small clusters which are likely to represent couples that are often composed of migrants from the same country of birth, and from risks associated with the Australian epidemic, which is largely driven by male-to-male sex. Within country of origin transmission networks accounted for a minority of transmission and the infections that occurred post-migration may have been preventable by timely diagnosis and ART treatment of partners living with HIV. Unfortunately previous findings from Australia and other high income countries are that migrants are at increased risk of delayed diagnosis \[[@pone.0237469.ref003], [@pone.0237469.ref028]--[@pone.0237469.ref032]\] and delayed ART treatment \[[@pone.0237469.ref033]\]. While there remains structural barriers to HIV testing and care for migrants in Australia, including a lack of access for some migrants to universal health coverage \[[@pone.0237469.ref033]\], qualitative research has also found that diverse groups of migrants to Australia perceive HIV risk in Australia to be low \[[@pone.0237469.ref034]\]. In addition to changes to eligibility universal health coverage that include migrants, non-stigmatising and culturally appropriate education about the risk of HIV and STIs in Australia in migrant groups may also be needed.

Limitations {#sec019}
-----------

Analysis of partial *pol* sequences obtained through routine clinical practice continues to be a key strategy for population genomic studies in HIV \[[@pone.0237469.ref011]\]. However, while phylogenetic clustering implies closely related infection, it does not necessarily imply direct transmission. It is possible that there were other infections in the transmission networks that have not yet been diagnosed, were diagnosed in another state or country and therefore were not notified in Victoria, were diagnosed prior to the study period, or did not have a *pol* sequence available. It is possible that some cases that were classified as having acquired HIV infection post-migration to Australia were exposed to HIV whilst travelling back to their country/region of birth or other regions abroad, which was not measured in this study. Furthermore, it was not possible to describe the possible transmission networks of those who were not in phylogenetic clusters.

Conclusions {#sec020}
===========

To the best of our knowledge, this is the first study to investigate the characteristics of possible HIV transmission networks specifically among heterosexual migrants. We found that post-migration risk of HIV infection in heterosexual migrants was attributable in part to sexual networks among migrants from the same country of origin (mostly pairs), but also attributable to larger sexual networks that included those born in Australia and New Zealand and those reporting male-to-male sex. A multipronged approach to prevention is warranted including promoting timely diagnosis and treatment of HIV infected migrants and non-stigmatising culturally appropriate education about HIV risk in Australia for migrants.

Supporting information {#sec021}
======================

###### Unadjusted and adjusted odds of phylogenetic clustering among partial *pol* sequences in 332 HIV 1 notifications 2005--2014 in heterosexuals with *pol* sequences available.

(DOCX)

###### 

Click here for additional data file.

###### Minimum data required to reproduce Tables [2](#pone.0237469.t002){ref-type="table"} & [3](#pone.0237469.t003){ref-type="table"} and [Fig 3](#pone.0237469.g003){ref-type="fig"}.

(XLS)

###### 

Click here for additional data file.
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1.    Please ensure that your manuscript meets PLOS ONE\'s style requirements, including those for file naming. The PLOS ONE style templates can be found at <http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf> and <http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf>

2\. In the ethics statement in the manuscript and in the online submission form, please provide additional information about the patient records used in your retrospective study. Specifically, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information.

3\. Thank you for stating the following in the Competing Interests section:

\"MS and MH have received investigator initiated funding from Gilead Sciences, AbbVie and Bristol Myers Squibb for research unrelated to this work.\"

Please confirm that this does not alter your adherence to all PLOS ONE policies on sharing data and materials, by including the following statement: \"This does not alter our adherence to  PLOS ONE policies on sharing data and materials." (as detailed online in our guide for authors [http://journals.plos.org/plosone/s/competing-interests](about:blank)).  If there are restrictions on sharing of data and/or materials, please state these. Please note that we cannot proceed with consideration of your article until this information has been declared.

Please include your updated Competing Interests statement in your cover letter; we will change the online submission form on your behalf.

Please know it is PLOS ONE policy for corresponding authors to declare, on behalf of all authors, all potential competing interests for the purposes of transparency. PLOS defines a competing interest as anything that interferes with, or could reasonably be perceived as interfering with, the full and objective presentation, peer review, editorial decision-making, or publication of research or non-research articles submitted to one of the journals. Competing interests can be financial or non-financial, professional, or personal. Competing interests can arise in relationship to an organization or another person. Please follow this link to our website for more details on competing interests: [http://journals.plos.org/plosone/s/competing-interests](about:blank)

4\. We note that you have indicated that data from this study are available upon request. PLOS only allows data to be available upon request if there are legal or ethical restrictions on sharing data publicly. For information on unacceptable data access restrictions, please see <http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions>.

In your revised cover letter, please address the following prompts:

a\) If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially identifying or sensitive patient information) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent.

b\) If there are no restrictions, please upload the minimal anonymized data set necessary to replicate your study findings as either Supporting Information files or to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. Please see <http://www.bmj.com/content/340/bmj.c181.long> for guidelines on how to de-identify and prepare clinical data for publication. For a list of acceptable repositories, please see <http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories>.

We will update your Data Availability statement on your behalf to reflect the information you provide.

5\. Please include your tables as part of your main manuscript and remove the individual files. Please note that supplementary tables (should remain/ be uploaded) as separate \"supporting information\" files.

6\. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: [http://journals.plos.org/plosone/s/supporting-information](about:blank).
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Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

2\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

4\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: No

\*\*\*\*\*\*\*\*\*\*

5\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: In the manuscript entitled "Phylogenetic clustering networks among heterosexual migrants with new HIV diagnoses post-migration in Australia", the authors addressed the structure of phylogenetic network among migrants in Australia focusing on heterosexually infected individuals. The theme of the study is important and understudied. The study is clearly presented. The results are interesting and significant. The authors identified a differential clustering associated with cluster size. In small clusters -- dyads, members were more likely to originate from the same country, while larger clusters were predominantly local and/or included members from different countries.

Minor critique:

\- A brief comparison on the current status of HIV epidemic (e.g., rates of prevalence and/or incidence) between the study site, state Victoria, and other regions across Australia might provide an idea whether study results could be extrapolated to the whole country.

\- Adding percentages might be helpful. For example, "Of these, 258 (30%) were in 92 phylogenetic clusters" gives the reader an idea about the proportion of clustered sequences. The authors provide some percentages, but there is some room for consistency.

\- The authors are making a parallel with the Netherlands epidemic, which makes sense, but at the same time raises question whether other HIV transmission networks around the word could be used to better understand the underlying processes in the local HIV-1 epidemic in the Victoria state in Australia.

\- The authors attempt to explain a large proportion of dyads by "heterosexually acquired infection among migrants mainly occurs within couples rather than larger sexual networks". This link is questionable. Cluster size distribution demonstrates that dyads predominate in the vast majority of HIV transmission networks.

\- The paragraph in Discussion before Limitations belongs rather to Introduction.

Reviewer \#2: In their manuscript entitled 'Phylogenetic clustering networks among heterosexual migrants with new HIV diagnoses post-migration in Australia, Sacks-Davis et al. used phylogenetic analysis of HIV-1 pol sequences of individuals infected with HIV-1 through heterosexual contacts and residing in the Australian state of Victoria. The major aim of the study was to look for indication for local transmission of the virus amongst migrants. The study is small but very well performed and the methodology used is appropriate. I particularly liked the approach to classify the evidence on probable place of HIV acquisition as 'strong' 'medium' or 'weak'. This is an elegant way to minimize as much as possible a bias due to the difficulty to reliable assess the infection time and place.

The results of the study show no evidence of transmission networks in the migrant population. Transmissions between migrants were mostly limited to one-to-one transmissions. This observation confirms the findings of others.

Remarks:

One of the conclusions of the study is that the larger clusters that include members of foreign origin mixed with Australian individuals are probably driven by male-to-male sex. This too is an observation that has been reported before in other countries and in that regards it is a bit unfortunate that the authors have limited their investigations to individuals reporting heterosexual contacts as risk behavior. The study would greatly benefit from the additional inclusion of MSM.

In the Methods section, the study population is not well described. Numbers for the different populations should be mentioned here. This information is only found in the subsequent paragraph of Phylogenetic clustering. Also information is missing on the selection criteria for the non-migrant population selected?

The text may benefit from some re-editing. At least the following sentences need to be reformulated for better understanding: in the abstract: 'Clusters of three or more ...'; in the section on Statistical analysis: 'on the basis of 859 sequences .....'; in the Discussion: 'The eight clusters consisting....'.

Also, the authors almost systematically write a comma before 'and'. There is no need to do this in case of enumerations, it inhibits a smooth reading. And I also would recommend to replace 'heterosexual sex' by 'heterosexual contact'.

\*\*\*\*\*\*\*\*\*\*

6\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No

\[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link \"View Attachments\". If this link does not appear, there are no attachment files.\]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <https://pacev2.apexcovantage.com/>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at <figures@plos.org>. Please note that Supporting Information files do not need this step.
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Reviewer 1 comments:

Comment 1: A brief comparison on the current status of HIV epidemic (e.g., rates of prevalence and/or incidence) between the study site, state Victoria, and other regions across Australia might provide an idea whether study results could be extrapolated to the whole country.

Author response: Additional detail has been added to the description of the HIV epidemic in Victoria in the Methods section (Study population subsection):

"Victoria is Australia's second most populous state and has the second highest number of people diagnosed with HIV and new HIV diagnoses \[25, 26\]."

Comment 2: Adding percentages might be helpful. For example, "Of these, 258 (30%) were in 92 phylogenetic clusters" gives the reader an idea about the proportion of clustered sequences. The authors provide some percentages, but there is some room for consistency.

Author response: Additional percentages have been added to the Results section as requested.

Comment 3: The authors are making a parallel with the Netherlands epidemic, which makes sense, but at the same time raises question whether other HIV transmission networks around the word could be used to better understand the underlying processes in the local HIV-1 epidemic in the Victoria state in Australia.

Author response: Thank you to the reviewers for this point. To the best of our knowledge, the model from the Netherlands is the only study of HIV transmission networks in migrants globally. While there are many studies of HIV diagnoses and cascades of care in migrants, studies examining whether migrants acquired infection prior to or after migration, and studies of transmission networks among MSM and PWID, we are not aware of any other studies on HIV transmission networks in migrant communities. This has been clarified in the manuscript (Discussion section, page 17):

"To the best of our knowledge, the only published study of HIV transmission networks in migrants is a mathematical modelling study of the heterosexual HIV epidemic in the Netherlands, which investigated the effects of sexual mixing patterns on the epidemic \[24\]."

If the reviewers are aware of other international studies that we have missed, we will add them to the manuscript.

Comment 4: The authors attempt to explain a large proportion of dyads by "heterosexually acquired infection among migrants mainly occurs within couples rather than larger sexual networks". This link is questionable. Cluster size distribution demonstrates that dyads predominate in the vast majority of HIV transmission networks.

Author's response: We agree with the reviewer that this sentence was misleading and have removed it from the Discussion.

Comment 5: The paragraph in Discussion before Limitations belongs rather to Introduction.

Authors' response: While most of this paragraph is a discussion of study findings, some of the details on previous research findings at the end of the paragraph were not directly linked to the study findings. We have removed some detail to make the connection between the latter part of the paragraph and study findings clearer.

Reviewer 2 comments:

Comment 1: One of the conclusions of the study is that the larger clusters that include members of foreign origin mixed with Australian individuals are probably driven by male-to-male sex. This too is an observation that has been reported before in other countries and in that regards it is a bit unfortunate that the authors have limited their investigations to individuals reporting heterosexual contacts as risk behavior. The study would greatly benefit from the additional inclusion of MSM.

Authors' response: We agree with the reviewer that inclusion of MSM would facilitate investigation of homosexual sexual transmission of HIV among migrants. Unfortunately, we did not have access to that data when we completed this analysis. This is an area where we would like to conduct future research.

Comment 2: In the Methods section, the study population is not well described. Numbers for the different populations should be mentioned here. This information is only found in the subsequent paragraph of Phylogenetic clustering. Also information is missing on the selection criteria for the non-migrant population selected?

Authors' response: Consistent with the STROBE checklist for reporting of cross-sectional studies, we have included participant numbers in the Results section rather than the Methods section. These are illustrated in the flow chart (Figure 1) and described in paragraphs 1 and 2 of the Results. We have clarified the selection criteria for the non-migrant population in the Methods as requested (Study population section):

"...all notifications in non-migrants aged\>18 years attributed to heterosexual sex and all notifications attributed to bisexual sex or injecting drug use (including those attributed to injecting drug use and MSM) in those \>18 years irrespective of migrant status."

Comment 3: The text may benefit from some re-editing. At least the following sentences need to be reformulated for better understanding: in the abstract: 'Clusters of three or more ...'; in the section on Statistical analysis: 'on the basis of 859 sequences .....'; in the Discussion: 'The eight clusters consisting....'.

Author response: Thank you for noting these difficult-to-read sentences. They have been amended as suggested. We have also re-edited the manuscript.

Comment 4: Also, the authors almost systematically write a comma before 'and'. There is no need to do this in case of enumerations, it inhibits a smooth reading.

Author response: Most of these commas have been removed as requested.

Comment 5: I also would recommend to replace 'heterosexual sex' by 'heterosexual contact'.

Author response: The HIV notification form refers to sexual contact. We have amended this and defined "heterosexual sex" as "heterosexual sexual contact" in the patient characteristics section of the Methods (page 6).

10.1371/journal.pone.0237469.r003
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Dear Dr. Sacks-Davis,

We're pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you'll receive an e-mail detailing the required amendments. When these have been addressed, you'll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at <http://www.editorialmanager.com/pone/>, click the \'Update My Information\' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at <authorbilling@plos.org>.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible \-- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact <onepress@plos.org>.

Kind regards,

Jason Blackard, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

None

Reviewers\' comments:

Reviewer\'s Responses to Questions

**Comments to the Author**

1\. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the "Comments to the Author" section, enter your conflict of interest statement in the "Confidential to Editor" section, and submit your \"Accept\" recommendation.

Reviewer \#1: All comments have been addressed

Reviewer \#2: All comments have been addressed

\*\*\*\*\*\*\*\*\*\*

2\. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

3\. Has the statistical analysis been performed appropriately and rigorously?

Reviewer \#1: Yes

Reviewer \#2: N/A

\*\*\*\*\*\*\*\*\*\*

4\. Have the authors made all data underlying the findings in their manuscript fully available?

The [PLOS Data policy](http://www.plosone.org/static/policies.action#sharing) requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data---e.g. participant privacy or use of data from a third party---those must be specified.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

5\. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer \#1: Yes

Reviewer \#2: Yes

\*\*\*\*\*\*\*\*\*\*

6\. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer \#1: (No Response)

Reviewer \#2: All remarks have been properly addressed. I have no further comments on the new version of the manuscript.

\*\*\*\*\*\*\*\*\*\*

7\. PLOS authors have the option to publish the peer review history of their article ([what does this mean?](https://journals.plos.org/plosone/s/editorial-and-peer-review-process#loc-peer-review-history)). If published, this will include your full peer review and any attached files.

If you choose "no", your identity will remain anonymous but your review may still be made public.

**Do you want your identity to be public for this peer review?** For information about this choice, including consent withdrawal, please see our [Privacy Policy](https://www.plos.org/privacy-policy).

Reviewer \#1: No

Reviewer \#2: No
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Phylogenetic clustering networks among heterosexual migrants with new HIV diagnoses post-migration in Australia

Dear Dr. Sacks-Davis:

I\'m pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they\'ll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact <onepress@plos.org>.

If we can help with anything else, please email us at <plosone@plos.org>.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Jason Blackard

Academic Editor

PLOS ONE
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